New York Association of Neuropathologists
Presented by: Dr. Ehud Lavi - New York Presbyterian Hospital
A 57-year-old woman presented in 2002 with a pineal region mass that was investigated
by MRI showing a relatively well circumscribed pineal mass of several centimeters, and a small
biopsy was taken. There was a recurrence in 2008, when the patient had a fall, urinary
incontinence and ataxia. In the intervening six years, there had been no treatment or symptoms.
The initial biopsy showed a small-cell lesion that had rosettes and the nuclei and other features
did not suggest any anaplasia. There were few if any mitotic figures, and no apoptotic bodies
were found. The Ki-67 mitotic labeling index was very low (hardly any positive nuclei were
present on a projected image). In 2008, she had papilledema during a follow-up examination for
diabetes, and this prompted further investigation. The daughter then reported a 6-week period of
episodic mutism. The patient was found to be mute, and MRI showed a very large pineal region
mass and obstructive hydrocephalus. Surgical debulking was undertaken. The recurrence was
high-grade with nuclear pleomorphism and mitoses. The Ki-67 labeling index was very high in
the 2008 specimen. The tumor was synaptophysin positive, focally neurofilament positive, and
negative for NeuN, GF AP, cytokeratin and leukocyte common antigen. There was a discussion
lead by Dr. Lavi regarding sampling error on the first sample versus tumor progression.
The 2002 tumor may have been a pineocytoma (WHO grade I) or pineal tumor of
intermediate grade (WHO grade II-III), and given the 6 years until recurrence, there was most
likely progression from a low-grade tumor to a high-grade tumor, diagnosed as a pineoblastoma
(WHO grade N), rather than the presence of any high-grade tumor to begin with.